Marliolide inhibits skin carcinogenesis by activating NRF2/ARE to induce heme oxygenase-1
- Authors
- Lee, June; Mailar, Karabasappa; Yoo, Ok-Kyung; Choi, Won Jun; Keum, Young-Sam
- Issue Date
- 25-Apr-2018
- Publisher
- ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
- Citation
- EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.150, pp 113 - 126
- Pages
- 14
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Volume
- 150
- Start Page
- 113
- End Page
- 126
- URI
- https://scholarworks.dongguk.edu/handle/sw.dongguk/9561
- DOI
- 10.1016/j.ejmech.2018.02.068
- ISSN
- 0223-5234
1768-3254
- Abstract
- Heme oxygenase-1 (HO-1) catalyzes the enzymatic degradation of heme to produce three anti-oxidant molecules: carbon monoxide (CO), ferrous ion (Fe2+), and biliverdin. Induction of HO-1 is currently considered as a feasible strategy to treat oxidative stress-related diseases. In the present study, we identified marliolide as a novel inducer of HO-1 in human normal keratinocyte HaCaT cells. Mechanism based studies demonstrated that the induction of HO-1 by marliolide occurred through activation of NRF2/ARE via direct binding of marliolide to KEAP1. Structure-activity relationship revealed chemical moieties of marliolide critical for induction of HO-1, which renders a support for Michael reaction as a potential mechanism of action. Finally, we observed that marliolide significantly inhibited the papilloma formation in DMBA/TPA-induced mouse skin carcinogenesis model and this event was closely associated with lowering the formation of 8-OH- G and 4-HNE in vivo. Together, our study provides the first evidence that marliolide might be effective against oxidative stress-related skin disorders. (C) 2018 Elsevier Masson SAS. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Pharmacy > Department of Pharmacy > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.